Article Details

Drug Update: First Person Dosed with Investigational Therapy AlloNK for Lupus Nephritis

Retrieved on: 2024-04-23 16:56:11

Tags for this article:

Click the tags to see associated articles and topics

Drug Update: First Person Dosed with Investigational Therapy AlloNK for Lupus Nephritis. View article details on hiswai:

Excerpt

It is designed to boost the efficacy of B-cell targeting monoclonal antibodies, which are used in treating diseases like LN by reducing the ...

Article found on: www.lupus.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up